BRUNO HOLTHOF

Bruno Holthof is a distinguished Partner at EQT Life Sciences, a leading global investment firm dedicated to backing innovative companies that are transforming the healthcare landscape. In his pivotal role, Dr. Holthof leverages his extensive operational and strategic expertise to identify, evaluate, and nurture groundbreaking ventures across the life sciences sector. His work at EQT Life Sciences is centered on driving significant advancements in patient care and medical technology through strategic capital deployment and active partnership with portfolio companies.

Dr. Holthof's investment focus at EQT Life Sciences is broad yet targeted, encompassing critical areas such as biotechnology, medical technology, diagnostics, and digital health. He is particularly interested in companies that are developing novel therapeutics, cutting-edge medical devices, advanced diagnostic tools, and transformative digital solutions designed to improve healthcare delivery and outcomes. His approach combines rigorous scientific and market analysis with a deep understanding of healthcare systems, ensuring that EQT Life Sciences invests in companies with strong potential for both commercial success and meaningful societal impact.

Before joining EQT Life Sciences, Dr. Holthof built an impressive career marked by significant leadership positions within the healthcare industry. Most notably, he served as the Chief Executive Officer of Oxford University Hospitals NHS Foundation Trust, one of the largest academic medical centers in the UK. During his tenure, he was instrumental in driving operational excellence, fostering innovation, and enhancing patient services across a complex healthcare system. Prior to his role at Oxford, Dr. Holthof was the CEO of the Antwerp University Hospital in Belgium, where he similarly spearheaded strategic initiatives that improved hospital performance and patient care.

His foundational experience also includes a tenure at McKinsey & Company, where he advised healthcare organizations on strategy and operations, further honing his analytical and problem-solving skills. Dr. Holthof’s background as a medical doctor provides him with a unique perspective, allowing him to deeply understand the clinical needs and scientific intricacies of the investments he considers. This blend of clinical insight, operational leadership, and strategic consulting experience makes him an invaluable asset to EQT Life Sciences and its portfolio companies.

At EQT Life Sciences, Bruno Holthof plays a crucial role in shaping the firm's investment strategy and contributing to its portfolio of groundbreaking companies. While specific individual investments are often part of a broader team effort, his expertise directly contributes to identifying and scaling companies poised to make a significant difference in global health. His commitment to fostering innovation and his proven track record in leading complex healthcare organizations underscore his dedication to advancing the life sciences sector for the benefit of patients worldwide.